Pharmacological Investigation of Tongqiao Jiuxin Oil Against High-Altitude Hypoxia: Integrating Chemical Profiling, Network Pharmacology, and Experimental Validation

Jiamei Xie, Yang Yang, Yuhang Du, Xiaohua Su, Yanling Zhao, Yongcheng An, Xin Mao, Menglu Wang, Ziyi Shan, Zhiyun Huang, Shuchang Liu, Baosheng ZhaoPharmaceuticals 2025 · DOI

TL;DR

This study investigates Tongqiao Jiuxin Oil (TQ), a traditional Chinese medicine, for its potential to treat acute mountain sickness (AMS). By combining chemical profiling, network pharmacology, and animal models, the researchers found that TQ effectively improves oxygenation, reduces tissue damage, and modulates key molecular pathways involved in hypoxia and apoptosis, suggesting its promise as an AMS intervention.

What Problem Does This Paper Address?

Acute mountain sickness (AMS) is a common and potentially dangerous condition that arises from rapid ascent to high altitudes, where the reduced oxygen levels (hypoxia) strain pulmonary and neurological functions. While traditional Chinese medicine formulas like Tongqiao Jiuxin Oil (TQ) have shown clinical promise for AMS, the underlying pharmacological mechanisms are not well understood. This paper aims to bridge this knowledge gap by systematically investigating TQ's efficacy and mechanisms against AMS, focusing on its effects on oxygen homeostasis, oxidative stress, and cellular apoptosis pathways.

Methods

The researchers employed a multi-pronged approach:

  • Chemical Profiling: Ultra-high-performance liquid chromatography coupled with Q-Exactive Orbitrap HRMS (UHPLC-Q-Exactive Orbitrap HRMS) was used to identify and characterize the chemical constituents of TQ.
  • Network Pharmacology: This approach was used to predict potential therapeutic targets and pathways involved in AMS by analyzing the identified TQ compounds and known AMS-related genes. Databases like SwissTargetPrediction, OMIM, and GeneCards were utilized, and a protein-protein interaction (PPI) network was constructed.
  • Animal Model: A rat model of AMS was established by exposing animals to hypobaric hypoxia (~10% oxygen), simulating an altitude of approximately 5500 meters.
  • Experimental Validation: In the AMS rat model, TQ was administered at different doses. The study then assessed various parameters, including:
  • Physiological Indices: Blood gas analysis (SaO2, PO2, pH, etc.) and hematological parameters (HGB, HCT, RBC).
  • Oxidative Stress Markers: Levels of malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione (GSH).
  • Histopathological Changes: Microscopic examination of lung, brain, liver, and heart tissues.
  • Molecular Mechanisms: Western blot analysis to measure the expression of key proteins involved in hypoxia (HIF-1α, VEGFA, EPO) and apoptosis (Bax, Bcl-2, Caspase-3) in lung and brain tissues.

Datasets

  • TQ Chemical Constituents: Identified using UHPLC-Q-Exactive Orbitrap HRMS. A total of 774 chemical constituents were identified.
  • Disease-Related Targets: Retrieved from OMIM and GeneCards databases using the keyword "acute mountain sickness."
  • Drug-Related Targets: Predicted using SwissTargetPrediction for TQ compounds.
  • Protein-Protein Interaction (PPI) Data: Obtained from the STRING database.
  • KEGG Pathway Enrichment: Analyzed using the DAVID database.

No new benchmarks were introduced; existing databases and analytical tools were utilized.

Key Insights and Ideas

  • Multi-component Synergy: TQ is a complex mixture, and its efficacy likely arises from the synergistic action of its numerous compounds, rather than a single active ingredient. This highlights the power of traditional herbal medicine.
  • Targeting Core AMS Pathways: The study successfully linked TQ's effects to critical pathways implicated in AMS, particularly the HIF-1α/VEGFA/EPO axis (involved in oxygen adaptation) and apoptosis pathways (involved in cell damage).
  • Holistic Protection: TQ demonstrated protective effects not only in the lungs and brain (primary targets of AMS) but also showed beneficial effects on liver and heart tissues, suggesting broader systemic protection.
  • Antioxidant Powerhouse: TQ significantly boosted endogenous antioxidant defenses (SOD, GSH) while reducing oxidative damage markers (MDA), a crucial mechanism for mitigating hypoxia-induced injury.
  • Modernizing TCM Research: The integration of chemical profiling, network pharmacology, and experimental validation provides a robust framework for understanding and validating traditional Chinese medicines.

Key Results

  • Chemical Composition: 774 chemical constituents were identified in TQ, with terpenoids being the most abundant class.
  • Network Pharmacology: Identified 70 overlapping targets between TQ and AMS, highlighting key pathways like HIF-1 signaling and VEGF signaling.
  • Physiological Improvements: TQ treatment significantly improved arterial oxygen saturation (SaO2) and partial pressure of oxygen (PO2) in AMS rats. It also helped restore pH levels and reduce carbon dioxide partial pressure.
  • Oxidative Stress Reduction: TQ administration led to increased SOD and GSH levels and a significant decrease in MDA levels in AMS rats.
  • Histopathological Protection: TQ treatment attenuated the severe lung and brain tissue damage observed in AMS rats, including reduced congestion, edema, and inflammatory infiltration.
  • Molecular Regulation: TQ downregulated the expression of hypoxia-related proteins (HIF-1α, VEGFA, EPO) and pro-apoptotic markers (Bax/Bcl-2 ratio, Caspase-3) while upregulating the anti-apoptotic protein Bcl-2 in both lung and brain tissues.

Limitations and Future Work

  • Pharmacokinetic Studies: The authors suggest that more detailed pharmacokinetic studies are needed to understand the distribution of individual TQ components (especially borneol and menthol) in target tissues like the brain and lungs.
  • Mechanistic Dissection: The use of gene knockout or overexpression models (e.g., HIF-1α-/- rats) is recommended to further dissect the precise signaling cascades modulated by TQ.
  • Clinical Validation: The ultimate step for establishing TQ's translational potential would be clinical validation in high-altitude-exposed populations or patients at risk of AMS.
  • Formulation Optimization: Future work could focus on optimizing TQ's formulation, identifying key active components, enhancing bioavailability, and developing advanced delivery systems for targeted action.

Summary updated

Abstract

<b>Background</b>: Acute mountain sickness (AMS) is a prevalent and potentially life-threatening condition caused by rapid exposure to high-altitude hypoxia, affecting pulmonary and neurological functions. Tongqiao Jiuxin Oil (TQ), a traditional Chinese medicine formula composed of aromatic and resinous ingredients such as sandalwood, agarwood, frankincense, borneol, and musk, has been widely used in the treatment of cardiovascular and cerebrovascular disorders. Clinical observations suggest its potential efficacy against AMS, yet its pharmacological mechanisms remain poorly understood. <b>Methods:</b> The chemical profile of TQ was characterized using UHPLC-Q-Exactive Orbitrap HRMS. Network pharmacology was applied to predict the potential targets and pathways involved in AMS. A rat model of AMS was established by exposing animals to hypobaric hypoxia (~10% oxygen), simulating an altitude of approximately 5500 m. TQ was administered at varying doses. Physiological indices, oxidative stress markers (MDA, SOD, GSH), histopathological changes, and the expression of hypoxia- and apoptosis-related proteins (HIF-1α, VEGFA, EPO, Bax, Bcl-2, Caspase-3) in lung and brain tissues were assessed. <b>Results</b>: A total of 774 chemical constituents were identified from TQ. Network pharmacology predicted the involvement of multiple targets and pathways. TQ significantly improved arterial oxygenation and reduced histopathological damage in both lung and brain tissues. It enhanced antioxidant activity by elevating SOD and GSH levels and reducing MDA content. Mechanistically, TQ downregulated the expression of HIF-1α, VEGFA, EPO, and pro-apoptotic markers (Bax/Bcl-2 ratio, Caspase-3), while upregulated Bcl-2, the anti-apoptotic protein expression. <b>Conclusions</b>: TQ exerts protective effects against AMS-induced tissue injury by improving oxygen homeostasis, alleviating oxidative stress, and modulating hypoxia-related and apoptotic signaling pathways. This study provides pharmacological evidence supporting the potential of TQ as a promising candidate for AMS intervention, as well as the modern research method for multi-component traditional Chinese medicine.
BibTeX
@inproceedings{xie2025pharmacological,
  author = {Jiamei Xie and Yang Yang and Yuhang Du and Xiaohua Su and Yanling Zhao and Yongcheng An and Xin Mao and Menglu Wang and Ziyi Shan and Zhiyun Huang and Shuchang Liu and Baosheng Zhao},
  title = {{Pharmacological Investigation of Tongqiao Jiuxin Oil Against High-Altitude Hypoxia: Integrating Chemical Profiling, Network Pharmacology, and Experimental Validation}},
  booktitle = {Pharmaceuticals},
  year = {2025},
  doi = {10.3390/ph18081153},
}
Figure